ELAN

21.52

0.37% -0.08

Dopo l'orario di chiusura: 21.52

Elanco Animal Health Inc (ELAN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$21.60

Aprire:

$21.74

Volume 24 ore:

6.95M

Relative Volume:

0.95

Capitalizzazione di mercato:

$10.69B

Reddito:

$4.45B

Utile/perdita netta:

$205.00M

Rapporto P/E:

53.80

EPS:

0.4

Flusso di cassa netto:

$372.00M

1 W Prestazione:

-4.65%

1M Prestazione:

+4.16%

6M Prestazione:

+126.29%

1 anno Prestazione:

+67.34%

Intervallo 1D:

$21.04

$21.95

Intervallo di 1 settimana:

$21.04

$22.98

Portata 52W:

$8.02

$22.98

Elanco Animal Health Inc Stock (ELAN) Company Profile

Nome

Elanco Animal Health Inc

Settore

Healthcare (1126)

Industria

Drug Manufacturers - Specialty & Generic (84)

Telefono

877-352-6261

Indirizzo

2500 INNOVATION WAY, GREENFIELD

Dipendente

9,450

Cinguettio

@Elanco

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

ELAN's Discussions on Twitter

Confronta ELAN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ELAN Elanco Animal Health Inc	21.52	10.73B	4.45B	205.00M	372.00M	0.40
ZTS Zoetis Inc	119.56	53.10B	9.40B	2.65B	2.22B	5.935
TAK Takeda Pharmaceutical Co Adr	13.64	42.93B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.41	41.46B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	24.46	28.22B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	454.00	19.27B	3.08B	1.24B	1.07B	25.61

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-07	Aggiornamento	JP Morgan	Neutral → Overweight
2025-07-17	Aggiornamento	Leerink Partners	Market Perform → Outperform
2025-06-26	Aggiornamento	William Blair	Mkt Perform → Outperform
2024-12-09	Iniziato	UBS	Buy
2024-12-02	Iniziato	Leerink Partners	Market Perform
2024-09-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Aggiornamento	Stifel	Hold → Buy
2023-12-19	Iniziato	Jefferies	Buy
2023-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-04-20	Aggiornamento	Barclays	Equal Weight → Overweight
2022-08-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Downgrade	JP Morgan	Overweight → Neutral
2022-07-21	Downgrade	Goldman	Buy → Sell
2022-07-12	Iniziato	Piper Sandler	Neutral
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-10-28	Downgrade	Stifel	Buy → Hold
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-06-15	Aggiornamento	Cleveland Research	Underperform → Neutral
2021-05-11	Aggiornamento	Barclays	Underweight → Equal Weight
2021-05-11	Aggiornamento	Gabelli & Co	Hold → Buy
2021-04-15	Iniziato	Stifel	Buy
2021-03-22	Downgrade	Gabelli & Co	Buy → Hold
2021-02-26	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-09	Downgrade	Argus	Buy → Hold
2020-11-09	Downgrade	Barclays	Overweight → Underweight
2020-08-20	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Ripresa	Credit Suisse	Neutral
2020-08-04	Ripresa	Goldman	Buy
2020-07-27	Downgrade	Cleveland Research	Neutral → Underperform
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Iniziato	Raymond James	Mkt Perform
2019-12-19	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-11-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Iniziato	Barclays	Overweight
2019-08-26	Downgrade	BofA/Merrill	Buy → Neutral
2019-08-15	Aggiornamento	UBS	Sell → Neutral
2019-05-23	Iniziato	Guggenheim	Neutral
2019-03-18	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-03-13	Ripresa	Morgan Stanley	Equal-Weight
2019-02-12	Iniziato	William Blair	Mkt Perform
2019-01-23	Iniziato	UBS	Sell
2019-01-15	Iniziato	Argus	Buy
2018-10-15	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Elanco Animal Health Inc Borsa (ELAN) Ultime notizie

01:04 AM

ELAN: UBS Maintains 'Buy' Rating and Raises Price Target to $27 - GuruFocus

01:04 AM

10:39 AM

How to integrate Elanco Animal Health Incorporated into portfolio analysis toolsPortfolio Gains Report & Consistent Profit Trade Alerts - newser.com

10:39 AM

07:00 AM

Will Elanco Animal Health Incorporated stock recover faster than marketJuly 2025 Recap & Free Daily Entry Point Trade Alerts - newser.com

07:00 AM

04:15 AM

What insider purchases suggest about Elanco Animal Health Incorporated (5EA) stockJuly 2025 Macro Moves & Weekly Top Stock Performers List - fcp.pa.gov.br

04:15 AM

04:03 AM

How cyclical is Elanco Animal Health Incorporated (5EA) stock compared to rivalsTrade Risk Report & Reliable Entry Point Alerts - newser.com

04:03 AM

01:50 AM

Is Elanco Animal Health Incorporated stock bottoming outPortfolio Value Report & Free Accurate Trade Setup Notifications - newser.com

01:50 AM

01:12 AM

Is Elanco Animal Health Incorporated (5EA) stock a buy on weaknessGap Down & Stepwise Trade Signal Implementation - newser.com

01:12 AM

12:33 PM

ELAN Q3 Deep Dive: Innovation Drives Growth, but Market Eyes Margin and Competition - Markets Financial Content

12:33 PM

12:19 PM

Risk vs reward if holding onto Elanco Animal Health IncorporatedQuarterly Growth Report & Community Driven Trade Alerts - newser.com

12:19 PM

12:09 PM

Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig - GuruFocus

12:09 PM

Nov 05, 2025

Elanco Animal Health Incorporated stock prediction for this weekJuly 2025 Update & Weekly Stock Breakout Alerts - newser.com

Nov 05, 2025

Why institutional investors increase stakes in Elanco Animal Health Incorporated stock2025 Retail Activity & High Return Stock Watch Alerts - newser.com

Nov 05, 2025

Best data tools to analyze Elanco Animal Health Incorporated stockQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com

Nov 05, 2025

Elanco Animal Health (ELAN): $606M One-Off Gain Raises Questions on Earnings Quality Versus Growth Hopes - simplywall.st

Nov 05, 2025

What is the fair value of Elanco Animal Health Incorporated stock now2025 Market Sentiment & Technical Entry and Exit Alerts - fcp.pa.gov.br

Nov 05, 2025

Elanco Ramps Up Growth as New Products Are Adopted - Morningstar

Nov 05, 2025